We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to identify and report harmful trade practices that affect your business when exporting, importing or operating domestically.
Actions that trial sponsors should consider to build resilience into clinical trial design
Find out about the penalties for enabling a defeated tax avoidance scheme, the time limits, and how to appeal a penalty notice.
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
The CMA is consulting on remedies that it should consider reviewing across its portfolio of market and merger remedies.
Guidance for prescribing vets on the use of the cascade.
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
Foreign, Commonwealth & Development Office (FCDO) advice for lesbian, gay, bisexual and transgender (LGBT+) people travelling abroad.
Guidance for the veterinary pharmaceutical industry on the production and submission of the Summary of Product Characteristics (SPCs) and product literature mock-ups.
A wholesale dealer in Great Britain may import Qualified Person certified medicines from the European Economic Area if certain checks are made by the ‘Responsible Person (import)’
Who in the pharmaceutical industry can be a Marketing Authorisation Holder, named distributor or local representative and how to make changes to these.
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
This guidance concerns the CMA's activities in monitoring and enforcing compliance with final merger and market undertakings and orders.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
The legal text underpinning the regulation of manufacture, authorisation, marketing, distribution, use and post-authorisation surveillance of veterinary medicines and medicated feed.
Explainer for the pharmaceutical industry on the implementation of Pharmacovigilance requirements during the transition time from the date the revised VMR have effect in GB to 17 May 2027.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).